|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Infertility | |||||
| 2 | More general conditions related to this trial | ||||
| Genital Diseases, Female | |||||
| Genital Diseases, Male | |||||
| 3 | Interventions listed in this trial | ||||
| DR-2011 | |||||
| Crinone 8% | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Progesterone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Progestins | |||||
| 6 | Sponsors listed in this trial | ||||
| Duramed Research | |||||